Сarcinomatosis Doctors in Turkey — Page 2

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr Volkan Kinas is an oncological surgeon at Büyük Anadolu Hospitals who focuses on complex cancer resections within the abdominal cavity.

• Specialises in surgical management of gastric and colon cancers
• Focuses on pancreatic and bile duct surgery for advanced cases
• Performs metabolic and bariatric surgery for patients with endocrine concerns
• Manages thyroid and breast cancer cases through targeted surgical techniques
• Focuses on oncological surgery to remove complex tumours from abdominal organs

Professor Elnur Sahibov is a radiation oncology specialist at Emsey Hospital who focuses on managing complex cases of carcinomatosis.

• Trained at Marmara University Faculty of Medicine – one of Turkey's premier medical institutions
• Specialises in radiation oncology for late-stage and metastatic conditions
• Provides evidence-based treatment protocols within a multidisciplinary oncology team
• Uses targeted radiotherapy to manage secondary cancer spreads effectively

Associate Professor Emrah Eraslan is a highly qualified medical oncologist at Private Koru Ankara Hospital specialising in the management of advanced malignancies including ovarian and colorectal cancers.

• Earned his Associate Professor title through extensive research in systemic cancer therapies
• Trained at the Abdurrahman Yurtaslan Oncology Hospital – a leading centre for cancer education
• Specialises in managing complex abdominal cases like carcinomatosis through systemic treatments
• Focuses on tailoring protocols for stomach and ovarian cancer patients